MarkS.AndersonMDPhD
Endocrinology • San Francisco, CADiabetes, Lipid Metabolism
Professor, Diabetes Center, UCSF School of Medicine
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2266Fax+1 415-353-2392
Education & Training
Harvard Medical SchoolPost-Doctoral Fellowship, 1999 - 2002
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
University of MinnesotaChief Residency, Internal Medicine, 1997 - 1998- University of MinnesotaResidency, Internal Medicine, 1994 - 1998
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1994
University of Chicago, Pritzker School of MedicinePhD, 1987 - 1992
Certifications & Licensure
CA State Medical License 2004 - 2025
MA State Medical License 1998 - 2003
MN State Medical License 1996 - 1998
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2009
Publications & Presentations
PubMed
- Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.Hailyn V Nielsen, Letitia Yang, James L Mueller, Alexander J Ritter, Ryosuke Hiwa
Nature Communications. 2025-01-17 - Monogenic Type 1 Diabetes: A High Yield Pool in Which to Discover New Mechanisms and Candidate Therapeutics for Type 1 Diabetes.Chester E Chamberlain, Michael S German, Louis H Philipson, Mark S Anderson
Cold Spring Harbor Perspectives in Medicine. 2024-12-18 - 3 citationsIncontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.Jérémie Rosain, Tom Le Voyer, Xian Liu, Adrian Gervais, Laura Polivka
The Journal of Experimental Medicine. 2024-11-04
Press Mentions
UChicago Medicine Names Mohamad Bydon, MD, as Inaugural Chair of the Department of Neurological SurgeryFebruary 10th, 2025- Ralph Weichselbaum, MD, Appointed University of Chicago Health System Leader for Radiation and Cellular OncologyDecember 4th, 2024
- University of Chicago Medical CenterNovember 15th, 2024
- Join now to see all
Grant Support
- Thymic Medullary Epithelial Cell Turnover And Control Of Immune ToleranceNational Institute Of Allergy And Infectious Diseases2012
- Aire-Defieciency As A Novel Model Of UveitisNational Eye Institute2005–2011
- Control Of Autoimmunity By Central ToleranceNational Institute Of Allergy And Infectious Diseases2006–2010
- AnimalsNational Institute Of Allergy And Infectious Diseases2006–2010
- Role Of The AIRE Gene In The Development Of AutoimmunityNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Role Of The AIRE Gene In The Development Of AutoimmunityNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
